D. Boral Capital Served as Co-Manager to ImmunityBio, Inc. (Nasdaq: IBRX) in connection with its $100.0 Million Underwritten Public Offering

D. Boral Capital LLC Provides Corporate Update, Reporting Strong Revenue Growth & Financial Position

D. Boral Capital projected 2024 revenues to be ~$100M, along with unaudited current net income of ~$25M with no debt & strongest balance sheet since inception

D. Boral Capital LLC to be Platinum Sponsor at The PIPEs Conference

NEW YORK, November 12, 2024 – D. Boral Capital, a relationship & performance driven investment bank focused on growth issuers and their investors, today announces it will be a Platinum sponsor of The PIPEs Conference (A DealFlow Event) being held November 13-14, 2024 at the Hard Rock Hotel & Casino in Hollywood, Fla.

D. Boral Capital Acted as Joint Bookrunner to Li Bang International Corporation Inc. (Nasdaq: LBGJ) in connection with its $6.1 Million Initial Public Offering

Jiangyin, China, Oct. 24, 2024 (GLOBE NEWSWIRE) — Li Bang International Corporation Inc. (Nasdaq: LBGJ) (the “Company” or “Li Bang”), a company engaged in designing, developing, producing, and selling stainless steel commercial kitchen equipment in China, today announced the closing of its initial public offering (the “Offering”) of 1,520,000 ordinary shares at a public offering… Continue reading D. Boral Capital Acted as Joint Bookrunner to Li Bang International Corporation Inc. (Nasdaq: LBGJ) in connection with its $6.1 Million Initial Public Offering